Kingfisher Capital LLC Edwards Lifesciences Corp Transaction History

Kingfisher Capital LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$57.54 - $76.95 $380,569 - $508,947	-6,614 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$52.41 - $81.0 $56,812 - $87,804	-1,084 Reduced 14.08%	6,614 $1.25 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $1,935 - $2,216	-27 Reduced 0.35%	7,698 $1.8 Million
Q3 2019 Nov 12, 2019	SELL	$61.55 - $75.43 $3,693 - $4,525	-60 Reduced 0.77%	7,725 $1.7 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $1,727 - $1,996	31 Added 0.4%	7,785 $1.44 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $909 - $1,216	-19 Reduced 0.24%	7,754 $1.48 Million
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $46 - $56	-1 Reduced 0.01%	7,773 $1.19 Million
Q3 2018 Nov 13, 2018	BUY	$45.7 - $58.03 $6,900 - $8,762	151 Added 1.98%	7,774 $1.35 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $23,389 - $28,266	-551 Reduced 6.74%	7,623 $1.11 Million
Q1 2018 May 16, 2018	BUY	$37.19 - $47.45 $260 - $332	7 Added 0.09%	8,174 $1.14 Million
Q4 2017 Feb 13, 2018	SELL	$33.79 - $39.39 $1,655 - $1,930	-49 Reduced 0.6%	8,167 $921,000
Q3 2017 Nov 06, 2017	SELL	$36.29 - $38.83 $8,637 - $9,241	-238 Reduced 2.82%	8,216 $898,000
Q2 2017 Aug 15, 2017	BUY	N/A	8,454	8,454 $1 Million

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Kingfisher Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Kingfisher Capital LLC with notifications on news.